This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

A Randomized Controlled Trial

Jeannie K. Lee, PharmD; Karen A. Grace, PharmD; Allen J. Taylor, MD

JAMA. 2006;296:(doi:10.1001/jama.296.21.joc60162).

Context  Poor medication adherence diminishes the health benefits of pharmacotherapies. Elderly patients with coronary risk factors frequently require treatment with multiple medications, placing them at increased risk for nonadherence.

Objective  To test the efficacy of a comprehensive pharmacy care program to improve medication adherence and its associated effects on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C).

Design, Setting, and Patients  A multiphase, prospective study with an observational phase and a randomized controlled trial conducted at the Walter Reed Army Medical Center of 200 community-based patients aged 65 years or older taking at least 4 chronic medications. The study was conducted from June 2004 to August 2006.

Intervention  After a 2-month run-in phase (measurement of baseline adherence, BP, and LDL-C), patients entered a 6-month intervention phase (standardized medication education, regular follow-up by pharmacists, and medications dispensed in time-specific packs). Following the intervention phase, patients were randomized to continued pharmacy care vs usual care for an additional 6 months.

Main Outcome Measures  Primary end point of the observation phase was change in the proportion of pills taken vs baseline; secondary end points were the associated changes in BP and LDL-C. Primary end point of the randomization phase was the between-group comparison of medication persistence.

Results  A total of 200 elderly patients (77.1% men; mean [SD] age, 78 [8.3] years), taking a mean (SD) of 9 (3) chronic medications were enrolled. Coronary risk factors included drug-treated hypertension in 184 patients (91.5%) and drug-treated hyperlipidemia in 162 (80.6%). Mean (SD) baseline medication adherence was 61.2% (13.5%). After 6 months of intervention, medication adherence increased to 96.9% (5.2%; P<.001) and was associated with significant improvements in systolic BP (133.2 [14.9] to 129.9 [16.0] mm Hg; P = .02) and LDL-C (91.7 [26.1] to 86.8 [23.4] mg/dL; P = .001). Six months after randomization, the persistence of medication adherence decreased to 69.1% (16.4%) among those patients assigned to usual care, whereas it was sustained at 95.5% (7.7%) in pharmacy care (P<.001). This was associated with significant reductions in systolic BP in the pharmacy care group (–6.9 mm Hg; 95% CI, –10.7 to –3.1 mm Hg) vs the usual care group (–1.0 mm Hg; 95% CI, –5.9 to 3.9 mm Hg; P = .04), but no significant between-group differences in LDL-C levels or reductions.

Conclusions  A pharmacy care program led to increases in medication adherence, medication persistence, and clinically meaningful reductions in BP, whereas discontinuation of the program was associated with decreased medication adherence and persistence.

Trial Registration  clinicaltrials.gov Identifier: NCT00393419

Published online November 13, 2006 (doi:10.1001/jama.296.21.joc60162).

Author Affiliations: Departments of Pharmacy (Drs Lee and Grace) and Cardiology (Dr Taylor), Walter Reed Army Medical Center, Washington, DC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Pharmacy Care Programs and Clinical Outcomes
Aldo Mariotto
JAMA. 2007;297(16):1771-1772.
EXTRACT | FULL TEXT  

Medication Therapy Management and Cost-Related Medication Nonadherence
Alexander B. Guirguis and Michelle M. Zingone
JAMA. 2008;300(10):1130.
EXTRACT | FULL TEXT  

Medication Therapy Management and Cost-Related Medication Nonadherence—Reply
Stephen B. Soumerai and Jeanne Madden
JAMA. 2008;300(10):1130-1131.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Challenges for Improving Medication Adherence
Ross J. Simpson, Jr
JAMA. 2006;296(21):2614-2616.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho et al.
Circulation 2009;119:3028-3035.
ABSTRACT | FULL TEXT  

The Team Education and Adherence Monitoring (TEAM) Trial: Pharmacy Interventions to Improve Hypertension Control in Blacks
Svarstad et al.
Circ Cardiovasc Qual Outcomes 2009;2:264-271.
ABSTRACT | FULL TEXT  

Promoting Medication Adherence in Older Adults ... and the Rest of Us
Kocurek
Diabetes Spectr. 2009;22:80-84.
ABSTRACT | FULL TEXT  

Macrovascular Complications of Diabetes Mellitus
Nuzum and Merz
Journal of Pharmacy Practice 2009;22:135-148.
ABSTRACT  

A 41-Year-Old African American Man With Poorly Controlled Hypertension: Review of Patient and Physician Factors Related to Hypertension Treatment Adherence
Cooper
JAMA 2009;301:1260-1272.
ABSTRACT | FULL TEXT  

Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge
Hassan and Lage
Am J Health Syst Pharm 2009;66:358-365.
ABSTRACT | FULL TEXT  

Does behaviour modification affect post-stroke risk factor control? Three-year follow-up of a randomized controlled trial
McManus et al.
Clin Rehabil 2009;23:99-105.
ABSTRACT  

Patient adherence and persistence with oral anticancer treatment
Ruddy et al.
CA Cancer J Clin 2009;59:56-66.
ABSTRACT | FULL TEXT  

Intervention design, implementation, and evaluation
Planas
Am J Health Syst Pharm 2008;65:1854-1863.
ABSTRACT | FULL TEXT  

Medication Therapy Management and Cost-Related Medication Nonadherence
Guirguis and Zingone
JAMA 2008;300:1130-1130.
FULL TEXT  

Medication Therapy Management and Cost-Related Medication Nonadherence--Reply
Soumerai and Madden
JAMA 2008;300:1130-1131.
FULL TEXT  

Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management
Machado et al.
The Annals of Pharmacotherapy 2008;42:1195-1207.
ABSTRACT | FULL TEXT  

The Year in Hypertension
Williams
J Am Coll Cardiol 2008;51:1803-1817.
FULL TEXT  

Model for medication therapy management in a university clinic
Kliethermes et al.
Am J Health Syst Pharm 2008;65:844-856.
ABSTRACT | FULL TEXT  

Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction
Jackevicius et al.
Circulation 2008;117:1028-1036.
ABSTRACT | FULL TEXT  

Review: fixed-dose drug combinations improve medication compliance compared with free-drug regimens
Bergmann,
Evid. Based Med. 2008;13:18-18.
FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT  

Cardiovascular Health Disparities: A Systematic Review of Health Care Interventions
Davis et al.
Med Care Res Rev 2007;64:29S-100S.
ABSTRACT  

Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
Gehi et al.
Arch Intern Med 2007;167:1798-1803.
ABSTRACT | FULL TEXT  

Clinical documentation for patient care: Models, concepts, and liability considerations for pharmacists
Zierler-Brown et al.
Am J Health Syst Pharm 2007;64:1851-1858.
ABSTRACT | FULL TEXT  

Pharmacy Care Programs and Clinical Outcomes
Mariotto
JAMA 2007;297:1771-1772.
FULL TEXT  

JournalScan
Lindsay
Heart 2007;93:536-538.
FULL TEXT  

Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT | FULL TEXT  

Challenges for Improving Medication Adherence
Simpson
JAMA 2006;296:2614-2616.
FULL TEXT